Liquid-crystal medium

US10519375B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10519375-B2
Application numberUS-201615571988-A
CountryUS
Kind codeB2
Filing dateApr 8, 2016
Priority dateMay 4, 2015
Publication dateDec 31, 2019
Grant dateDec 31, 2019

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The invention relates to a liquid-crystalline medium which comprises at least one compound of the formula I, in which R 1 and R 1 * each, independently of one another, denote an alkyl or alkoxy radical having 1 to 15 C atoms, where, in addition, one or more CH 2 groups in these radicals may each be replaced, independently of one another, by in such a way that O atoms are not linked directly to one another, and in which, in addition, one or more H atoms may be replaced by halogen, A 1 denotes L 1 denotes F, Cl, CF 3 , OCF 3 or CHF 2 , and to the use thereof for electro-optical purposes, in particular for shutter glasses, 3D applications, in TN, PS-TN, STN, TN-TFT, OCB, IPS, PS-IPS, FFS, PS-FFS and PS-VA-IPS displays.

First claim

Opening claim text (preview).

The invention claimed is: 1. A liquid-crystalline medium, comprising at least one compound of formula I, in which R 1 and R 1 * each, independently of one another, denote an alkyl or alkoxy radical having 1 to 15 C atoms, in which one or more CH 2 groups are optionally each replaced, independently of one another, by  in such a way that O atoms are not linked directly to one another, and in which optionally one or more H atoms are replaced by halogen, A 1 denotes L 1 denotes F, Cl, CF 3 , OCF 3 or CHF 2 . 2. A liquid-crystalline medium, comprising at least one compound of formulae I-1 to I-10, in which A 1 denotes L 1 denotes F, Cl, CF 3 , OCF 3 or CHF 2 , alkyl and alkyl* each, independently of one another, denote a straight-chain alkyl radical having 1-6 C atoms, alkenyl and alkenyl* each, independently of one another, denote a straight-chain alkenyl radical having 2-6 C atoms, and alkoxy and alkoxy* each, independently of one another, denote a straight-chain alkoxy radical having 1-6 C atoms. 3. The liquid-crystalline medium according to claim 1 , which additionally comprises one or more compounds of formulae II and/or III, in which R 0 denotes a halogenated or unsubstituted alkyl or alkoxy radical having 1 to 15 C atoms, in which one or more CH 2 groups are optionally each replaced, independently of one another, by  in such a way that O atoms are not linked directly to one another, X 0 denotes F, Cl, CN, SF 5 , SCN, NCS, a halogenated alkyl radical, a halogenated alkenyl radical, a halogenated alkoxy radical or a halogenated alkenyloxy radical having up to 6 C atoms, Y 1-6 each, independently of one another, denote H, F or Cl,  each, independently of one another, denote 4. The liquid-crystalline medium according to claim 1 , which additionally comprises one or more compounds of formulae IX to XII, in which X 0 denotes F, Cl, CN, SF 5 , SCN, NCS, a halogenated alkyl radical, a halogenated alkenyl radical, a halogenated alkoxy radical or a halogenated alkenyloxy radical having up to 6 C atoms, L denotes H or F, “alkyl” denotes C 1-6 -alkyl, R′ denotes C 1-6 -alkyl, C 1-6 -alkoxy or C 2-6 -alkenyl, and “alkenyl” and “alkenyl*” each, independently of one another, denote C 2-6 -alkenyl. 5. The liquid-crystalline medium according to claim 1 , which additionally comprises one or more compounds of formula XIII, in which R 1 and R 2 each, independently of one another, denote n-alkyl, alkoxy, oxaalkyl, fluoroalkyl or alkenyl, each having up to 6 C atoms. 6. The liquid-crystalline medium according to claim 1 , which additionally comprises one or more compounds of formula XVII, in which R 1 and R 2 each, independently of one another, denote n-alkyl, alkoxy, oxaalkyl, fluoroalkyl or alkenyl, each having up to 8 C atoms, and L denotes H or F. 7. The liquid-crystalline medium according to claim 1 , which additionally comprises one or more compounds of formulae XXVII, XXVIII and/or XXIX, in which R 0 denotes a halogenated or unsubstituted alkyl or alkoxy radical having 1 to 15 C atoms, in which one or more CH 2 groups are optionally each replaced, independently of one another, by  in such a way that O atoms are not linked directly to one another, and X 0 denotes F, Cl, CN, SF 5 , SCN, NCS, a halogenated alkyl radical, a halogenated alkenyl radical, a halogenated alkoxy radical or a halogenated alkenyloxy radical having up to 6 C atoms. 8. The liquid-crystalline medium according to claim 1 , which additionally comprises one or more compounds of formulae XIX, XX, XXI, XXII, XXIII and/or XXIV, in which R 0 denotes a halogenated or unsubstituted alkyl or alkoxy radical having 1 to 15 C atoms, in which one or more CH 2 groups are optionally each replaced, independently of one another, by  in such a way that O atoms are not linked directly to one another, X 0 denotes F, Cl, CN, SF 5 , SCN, NCS, a halogenated alkyl radical, a halogenated alkenyl radical, a halogenated alkoxy radical or a halogenated alkenyloxy radical having up to 6 C atoms, and Y 1-4 each, independently of one another, denote H or F. 9. The liquid-crystalline medium according to claim 1 , which additionally comprises one or more additive(s) selected from the group consisting of UV stabilisers, dopants and antioxidants. 10. The liquid-crystalline medium according to claim 1 , which additionally comprises one or more polymerisable compounds. 11. A process for preparing the liquid-crystalline medium according to claim 1 , comprising mixing one or more compounds of formula I with further liquid-crystalline compounds and optionally also with one or more additives and/or at least one polymerisable compound. 12. An electro-optical device, comprising the liquid-crystalline medium according to claim 1 . 13. The electro-optical device according to claim 12 , which is selected from the group consisting of shutter glasses, 3D applications, TN, PS-TN, STN, TN-TFT, OCB, IPS, PS-IPS, FFS, PS-FFS and PS-VA-IPS displays. 14. An electro-optical liquid-crystal display containing a liquid-crystalline medium according to claim 1 . 15. The liquid-crystalline medium according to claim 1 , wherein A 1 denotes 16. The liquid-crystalline medium according to claim 1 , wherein A 1 denotes 17. The liquid-crystalline medium according to claim 1 , wherein A 1 denotes

Assignees

Inventors

Classifications

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10519375B2 cover?
The invention relates to a liquid-crystalline medium which comprises at least one compound of the formula I, in which R 1 and R 1 * each, independently of one another, denote an alkyl or alkoxy radical having 1 to 15 C atoms, where, in addition, one or more CH 2 groups in these radica…
Who is the assignee on this patent?
Merck Patent Gmbh
What technology area does this patent fall under?
Primary CPC classification C09K19/062. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Dec 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).